EDGAR Filing Documents for 0001358403-15-000057

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001358403-15-000057

Filing Date

2015-07-17

Accepted

2015-07-17 16:59:25

Documents

Period of Report

2015-07-15

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 4	wf-form4_143716675579086.html	4
1	FORM 4	wf-form4_143716675579086.xml	4	7414
2	POWER OF ATTORNEY	ex-24.htm	EX-24	3160
	Complete submission text file	0001358403-15-000057.txt		12087

Mailing Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030

Business Address 2130 WEST HOLCOMBE BOULEVARD SUITE 800 HOUSTON TX 77030 (832) 384-1100

BELLICUM PHARMACEUTICALS, INC (Issuer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BELLICUM PHARMACEUTICALS, INC. 2130 W. HOLCOMBE BLVD., STE. 800 HOUSTON TX 77030

Business Address

Type: 4 | Act: 34 | File No.: 001-36783 | Film No.: 15994259